intTypePromotion=1
zunia.vn Tuyển sinh 2024 dành cho Gen-Z zunia.vn zunia.vn
ADSENSE

Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/ or recurrent osteosarcoma (EuroSarc-Memos trial)

Chia sẻ: _ _ | Ngày: | Loại File: PDF | Số trang:14

10
lượt xem
2
download
 
  Download Vui lòng tải xuống để xem tài liệu đầy đủ

The phase III clinical study of adjuvant liposomal muramyl tripeptide (MTP-PE) in resected high-grade osteosarcoma (OS) documented positive results that have been translated into regulatory approval, supporting initial promise for innate immune therapies in OS.

Chủ đề:
Lưu

Nội dung Text: Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/ or recurrent osteosarcoma (EuroSarc-Memos trial)

ADSENSE

CÓ THỂ BẠN MUỐN DOWNLOAD

 

Đồng bộ tài khoản
2=>2